| A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults 2004 · CVT-E002-treated group · Institutionalized older adults in nursing homes and assisted-living facilities; average ages 81 and 83.5 years across the two trials; 74% women | 400 mg | 12 weeks | 97 |
| Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial 2020 · Xinyue capsule group · Patients with stable coronary artery disease who underwent percutaneous coronary intervention 3–12 months earlier; age and sex not specified | 300 mg | 24 weeks | — |
| A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia 2012 · CVT-E002 · Adults aged 18 or older with chronic lymphocytic leukemia | 400 mg | — | 147 |
| Ginseng Berry Concentrate Alleviates Fatigue in Humans: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial 2025 · GBC · Adults aged 30–64 years experiencing daily fatigue, with CIS scores above 76 | 1 g | 8 weeks | 44 |
| Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study 2010 · 400 mg Cereboost™ · Healthy adults aged 18–40 years, both sexes, with no stated medical condition | 400 mg | 1 day | 32 |
| Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults 2002 · Ginseng · Healthy young adult volunteers; age range and sex not stated | 400 mg | 1 day | 20 |
| Efficacy of COLD-fX in the prevention of respiratory symptoms in community-dwelling adults: a randomized, double-blinded, placebo controlled trial 2006 · COLD-fX group · Community-dwelling adults aged 65 years or older; immunocompetent seniors without a stated illness | 400 mg | 120 days | — |
| Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA 2010 · 750 mg/day ginseng group · Adults with cancer-related fatigue, with a history of cancer and fatigue for at least 1 month | 750 mg | 8 weeks | — |
| Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA 2010 · 1,000 mg/day ginseng group · Adults with cancer-related fatigue, with a history of cancer and fatigue for at least 1 month | 1 g | 8 weeks | — |
| Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study 2013 · ginseng · female patients with multiple sclerosis | 500 mg | 90 days | — |
| Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected] 1996 · G115 group · Adult volunteers visiting three private practices in Milan; sex and age not reported | 100 mg | 12 weeks | 114 |
| Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by shengxueling 2007 · SXL-treated group · Adults with refractory idiopathic thrombocytopenic purpura (ITP) | 120 mg | 8 weeks | 37 |
| Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefolius L.) to healthy middle-age adults 2015 · American ginseng · Healthy adults aged 40–60 years | 200 mg | 1 day | 52 |
| Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study 2010 · 200 mg Cereboost™ · Healthy adults aged 18–40 years, both sexes, with no stated medical condition | 200 mg | 1 day | 32 |
| A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action 2022 · Cereboost® group · Healthy adults aged 18–40 years | 200 mg | 2 weeks | 30 |
| Effects of Panax quinquefolius (American ginseng) on the steady state visually evoked potential during cognitive performance 2020 · Panax quinquefolius treatment · Adults aged 40–60 years; healthy volunteers, 7 women and 13 men | 200 mg | 1 day | 20 |
| Panax notoginseng supplementation enhances physical performance during endurance exercise 2005 · experimental (EXP) · Untrained adults aged 20–35 years | 1.35 g | 30 days | 13 |
| Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease 2012 · 1.5 g/day group · Patients with moderately severe Alzheimer's disease | 1.5 g | 24 weeks | 10 |
| Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA 2010 · 2,000 mg/day ginseng group · Adults with cancer-related fatigue, with a history of cancer and fatigue for at least 1 month | 2 g | 8 weeks | — |
| Effects of Korean ginseng berry extract on sexual function in men with erectile dysfunction: a multicenter, placebo-controlled, double-blind clinical study 2013 · standardized Korean ginseng berry (SKGB) · men with mild-to-moderate erectile dysfunction | 1.4 g | 8 weeks | — |
| Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2 2013 · ginseng arm · Fatigued cancer survivors; age range and sex not reported | 2 g | 8 weeks | — |
| Comparison of the effects of N-acetyl-cysteine and ginseng in prevention of noise induced hearing loss in male textile workers 2014 · Group II · Male textile workers exposed to continuous occupational noise | 200 mg | 2 weeks | — |
| Anti-Fatigue Effects of Enzyme-Modified Ginseng Extract: A Randomized, Double-Blind, Placebo-Controlled Trial 2016 · EMGE · Healthy adults | 2 g | 4 weeks | — |
| Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study 2010 · 100 mg Cereboost™ · Healthy adults aged 18–40 years, both sexes, with no stated medical condition | 100 mg | 1 day | 32 |
| Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease 2012 · 3 g/day group · Patients with moderately severe Alzheimer's disease | 3 g | 24 weeks | 10 |
| Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease 2012 · 4.5 g/day group · Patients with moderately severe Alzheimer's disease | 4.5 g | 24 weeks | 10 |
| Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand 2002 · Ginkgo-Ginseng combination, 320 mg · Healthy young adults, mean age 21 years | 320 mg | 1 day | — |
| Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand 2002 · Ginkgo-Ginseng combination, 640 mg · Healthy young adults, mean age 21 years | 640 mg | 1 day | — |
| Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand 2002 · Ginkgo-Ginseng combination, 960 mg · Healthy young adults, mean age 21 years | 960 mg | 1 day | — |
| The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial 2019 · Shenmai group · Adults with coronary artery disease who underwent coronary artery bypass grafting and could complete the 6-minute walking test without assistance or severe comorbidity | 3.6 g | 39 days | — |
| Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled study 2024 · polyphenolic-rich supplement · Healthy adults aged 35–65 years | 100 mg | 4 weeks | — |
| Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial 2019 · American ginseng extract · Adults with type 2 diabetes controlled by conventional treatment; age 64 ± 7 years; 11 women and 13 men | 3 g | 8 weeks | 24 |
| Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 diabetes: A randomized controlled trial 2020 · Rg3-KRG + AG co-administration · Adults with type 2 diabetes and hypertension | 6.75 g | 12 weeks | — |
| Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial 2016 · URSA Complex · Adults older than 19 with persistent or chronic fatigue for at least 1 month and a baseline CIS score of at least 76; both sexes | 100 mg | 4 weeks | 81 |
| A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans 2020 · Blueberry extract beverage · Healthy adults aged 18–35 years, males and females | 170 mg | 1 day | 32 |
| A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans 2020 · Apple extract beverage · Healthy adults aged 18–35 years, males and females | 170 mg | 1 day | 32 |
| A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans 2020 · Coffee berry extract beverage · Healthy adults aged 18–35 years, males and females | 170 mg | 1 day | 32 |
| Responder Analysis of Daikenchuto Treatment for Constipation in Poststroke Patients: A Subanalysis of a Randomized Control Trial 2019 · DKT treatment group · Men and women aged over 20 years with functional constipation after stroke, with stroke stable for at least 6 months | 3 g | 4 weeks | 17 |
| Efficacy and safety of red ginseng extract powder (KGC05pg) in achieving glycemic control in prediabetic Korean adults: A 12-week, single-center, randomized, double-blind, parallel-group, placebo-controlled study 2024 · RGEP group · Korean men and women aged 19 years or older with prediabetes | 500 mg | 12 weeks | 49 |
| [Effect of total saponins of Panax notoginseng on urinary albumin in patients with chronic renal failure] 2010 · experimental group · Patients with non-uremic chronic renal failure | 450 mg | 60 days | 30 |
| Effect of Ginseng Extracts on the Improvement of Osteopathic and Arthritis Symptoms in Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2021 · GE 1 g group (low) · Postmenopausal women over 40 years old with osteopenia | 1 g | 12 weeks | 30 |
| Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial 2014 · Rg3-KRG extract · Healthy adults aged 25 ± 2 years; 9 males and 14 females | 400 mg | 1 day | 23 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 1 g American ginseng, 40 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 1 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 1 g American ginseng, 20 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 1 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 1 g American ginseng, 10 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 1 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 1 g American ginseng, 0 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 1 g | 1 day | 12 |
| American ginseng supplementation induces an oxidative stress in postmenopausal women 2009 · American ginseng group · Women aged 55–75 who were postmenopausal | 500 mg | 120 days | 12 |
| Co-administration of a konjac-based fibre blend and American ginseng (Panax quinquefolius L.) on glycaemic control and serum lipids in type 2 diabetes: a randomized controlled, cross-over clinical trial 2018 · KGB and AG · Adults with type 2 diabetes, aged 64 ± 7 years; 18 men and 12 women completed the study | 3 g | 12 weeks | — |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 2 g American ginseng, 40 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 2 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 2 g American ginseng, 20 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 2 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 2 g American ginseng, 10 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 2 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 2 g American ginseng, 0 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 2 g | 1 day | 12 |
| Effect of Ginseng Extracts on the Improvement of Osteopathic and Arthritis Symptoms in Women with Osteopenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2021 · GE 3 g group (high) · Postmenopausal women over 40 years old with osteopenia | 3 g | 12 weeks | 30 |
| Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus 2014 · Korean red ginseng group · People with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus | 5 g | 12 weeks | 21 |
| Effects of Panax notoginseng (Chinese ginseng) and acute exercise on postprandial glycemia in non-diabetic adults 2012 · ginseng (G) + exercise (G+Ex) · Men aged 20–45 years who were untrained and non-diabetic | 3 g | 3 days | 14 |
| Effects of Panax notoginseng (Chinese ginseng) and acute exercise on postprandial glycemia in non-diabetic adults 2012 · ginseng (G) · Men aged 20–45 years who were untrained and non-diabetic | 3 g | 3 days | 13 |
| Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals 2015 · whole root AG · Healthy adults; mean age 28.9 years; 5 men and 8 women | 3 g | 1 day | 13 |
| Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals 2015 · AG-30% ethanol extract · Healthy adults; mean age 28.9 years; 5 men and 8 women | 3 g | 1 day | 13 |
| Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals 2015 · AG-50% ethanol extract · Healthy adults; mean age 28.9 years; 5 men and 8 women | 3 g | 1 day | 13 |
| Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals 2015 · AG-70% ethanol extract · Healthy adults; mean age 28.9 years; 5 men and 8 women | 3 g | 1 day | 13 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 3 g American ginseng, 40 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 3 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 3 g American ginseng, 20 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 3 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 3 g American ginseng, 10 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 3 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals 2001 · 3 g American ginseng, 0 min before glucose challenge · Healthy adults without diabetes; mean age 42 years | 3 g | 1 day | 12 |
| Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides 2004 · American ginseng · Healthy adults, 34 ± 3 years; 6 men and 6 women | 3 g | 1 day | 12 |
| Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides 2004 · American-wild ginseng · Healthy adults, 34 ± 3 years; 6 men and 6 women | 3 g | 1 day | 12 |
| Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides 2004 · Vietnamese-wild ginseng · Healthy adults, 34 ± 3 years; 6 men and 6 women | 3 g | 1 day | 12 |
| American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus 2000 · American ginseng 40 minutes before glucose challenge — nondiabetic subjects · Nondiabetic subjects; mean age 34 years | 3 g | 1 day | 10 |
| American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus 2000 · American ginseng together with glucose challenge — nondiabetic subjects · Nondiabetic subjects; mean age 34 years | 3 g | 1 day | 10 |
| American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus 2000 · American ginseng 40 minutes before glucose challenge — subjects with type 2 diabetes mellitus · Subjects with type 2 diabetes mellitus; mean age 62 years | 3 g | 1 day | 9 |
| American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus 2000 · American ginseng together with glucose challenge — subjects with type 2 diabetes mellitus · Subjects with type 2 diabetes mellitus; mean age 62 years | 3 g | 1 day | 9 |
| Supplementation of cheonggukjang and red ginseng cheonggukjang can improve plasma lipid profile and fasting blood glucose concentration in subjects with impaired fasting glucose 2011 · RGCH · Adults with impaired fasting glucose; mean age 44.9 years; 27 men and 18 women across the study | 20 g | 8 weeks | — |
| Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension 2013 · American ginseng extract · Adults with type 2 diabetes and concomitant hypertension; mean age 63 ± 9.3 years | 3 g | 12 weeks | — |
| Effects of ginseng on peripheral blood mitochondrial DNA copy number and hormones in men with metabolic syndrome: A randomized clinical and pilot study 2016 · RG group · Men with metabolic syndrome | 3 g | 4 weeks | — |
| Effect of the combination of ginseng, oriental bezoar and glycyrrhiza on autonomic nervous activity as evaluated by power spectral analysis of HRV and cardiac depolarization-repolarization process 2008 · Kampo · 10 healthy men; age not reported | 250 mg | 1 day | 10 |
| Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides 2004 · Japanese-rhizome ginseng · Healthy adults, 34 ± 3 years; 6 men and 6 women | 3 g | 1 day | 12 |
| Decreasing, null and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices in healthy humans: the role of ginsenosides 2004 · Sanchi ginseng · Healthy adults, 34 ± 3 years; 6 men and 6 women | 3 g | 1 day | 12 |